Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial
暂无分享，去创建一个
B. Strober | A. Gottlieb | M. Gooderham | K. Papp | P. Foley | K. Gordon | Subhashish Banerjee | J. Merola | M. Menter | L. Puig | D. Thaçi | A. Morita | Y. Elbez | J. Ye | M. Colombo | A. Napoli | Lan Wei | R. Kisa | Andrew A. Napoli